Belgium-based genae, a global CRO and services provider for the medical industries, has launched genae Japan in Tokyo.
Japan has the second-largest healthcare market in the world. Market growth factors include the rise of chronic diseases, an aging population and the increase of home-based care as a result. Globally, Japan has the highest percentage of citizens over the age of 65—a figure that also is growing more rapidly than in Western nations.
Asia’s increasing economic development drives a new medical device industry, particularly in Japan, China, Vietnam and Malaysia. The Southeast Asian medical device market is expected to grow to $10 billion by 2020.
The rapidly expanding markets in Asiaalso fuel continuous regulatory changes that focus on streamlining and optimizing testing and monitoring processes worldwide. Rigorous long-term monitoring and reporting of adverse effects is required after the device becomes available on the market.